How does the medicines retail sector ensure continued access to medicines during public health emergencies? Lessons from the COVID-19 pandemic in Uganda by Eleanor Hutchinson, Sunday Mundua, Jessica Myers, Sian E. Clarke, Kristian Schultz Hansen, Chrispus Mayora, Freddie Ssengooba, Freddy Eric Kitutu

“…Journal of Pharmaceutical Policy and Practice…”
Get full text

The prevalence of thromboembolic events among COVID-19 patients admitted to a single centre intensive care unit (ICU): an epidemiological study from a Malaysian population by Nur Farhani Mansor, Izzati Abdul Halim Zaki, Lee Chew Kiok, Eng Kar Seng, Tharmini Ravi, Mohan Pathmanathan, Khang Wen Goh, Long Chiau Ming, Pakhrur Razi, Hanis Hanum Zulkifly

“…Journal of Pharmaceutical Policy and Practice…”
Get full text

Understanding the regulatory-procurement interface for medicines in Africa via publicly available information on standards, implementation, and enforcement in five countries by Jillian C. Kohler, Mariangela Castro-Arteaga, Saher Panjwani, David Mukanga, Murray M. Lumpkin, Bonface Fundafunda, Anthony B. Kapeta, Chimwemwe Chamdimba, Anna S. Y. Wong, Kristin N. Harper, Charles Preston

“…Journal of Pharmaceutical Policy and Practice…”
Get full text

Payment models and the sustainability of community pharmacy practice: a qualitative interview study with community pharmacists by Kelly Ann Schmidtke, Terri Warholak

“…Journal of Pharmaceutical Policy and Practice…”
Get full text

‘We need to be part of the solution’: lessons from the 2024 PPRI Conference on ensuring access to affordable medicines through innovative policies by Sabine Vogler, Nina Zimmermann, Verena Knoll, Maximilian Salcher-Konrad, Friederike Windisch, Jaime Espin, Aukje K. Mantel-Teeuwisse, Dimitra Panteli, Fatima Suleman, Veronika J. Wirtz, Zaheer-Ud-Din Babar

“…Journal of Pharmaceutical Policy and Practice…”
Get full text

Medical students' exposure to and attitudes about the pharmaceutical industry: a systematic review. by Kirsten E Austad, Jerry Avorn, Aaron S Kesselheim

“…<h4>Methods and findings</h4>We performed a systematic review reported according to PRISMA guidelines to determine the frequency and nature of medical students' exposure to the drug industry, as well as students' attitudes concerning pharmaceutical policy issues. We searched MEDLINE, EMBASE, Web of Science, and ERIC from the earliest available dates through May 2010, as well as bibliographies of selected studies. …”
Get full text

A novel social-network-analysis-based approach for analyzing complex network of actors involved in accessibility of anti-cancer medications in Iran by Kamran Bagheri Lankarani, Leila Zarei, Esmaeil Alinezhad, Adel Sadeghdoost

“…Then, the influence relationships of these actors were comprehensively analysed through in-depth interviews with nine key informants involved in pharmaceutical policies through a structured questionnaire. …”
Get full text

Reform of economic evaluation of medicines in Spain: proposals from the Advisory Committee for Pharmaceutical Financing by Marta Trapero-Bertran, Jaume Puig-Junoy, Emilio J. Alegre-del-Rey, Ana Clopés, Félix Lobo, Ana Ortega

“…The initiatives of the CAPF aim to make progress towards the integration of efficiency in Spanish pharmaceutical policy seeking to improve the methodological quality and transparency of economic evaluations, ultimately contributing to more informed decision-making and sustainable healthcare practices. …”
Get full text